An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: use of mixed-model analyses
- PMID: 16507344
- DOI: 10.1016/j.schres.2005.12.851
An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: use of mixed-model analyses
Abstract
The purpose of this study was to evaluate the trajectory of neuropsychological performance among middle-aged and older patients with schizophrenia using hierarchical linear modeling (HLM). Using the Mattis Dementia Rating Scale (DRS), we assessed cognitive performance of 143 schizophrenia outpatients (Mean age=53.1 years, SD=8.8) and 66 healthy comparison subjects (Mean age=61.8 years, SD=8.8). All participants had DRS data from two or more testing sessions with average intervals between sessions being 15 months (range=6-55). Using HLM, we found cognitive performance to be stable over time in both schizophrenia patients and healthy comparison subjects. Age, gender, ethnicity, and education did not affect trajectories. We also analyzed the data using more traditional statistical approaches to longitudinal data and found similar results. In sum, we found cognitive impairment to be stable over time among outpatients with schizophrenia, regardless of the statistical methodology used to analyze longitudinal data.
Similar articles
-
Age-related practice effects across longitudinal neuropsychological assessments in older people with schizophrenia.Neuropsychology. 2010 Sep;24(5):616-24. doi: 10.1037/a0019560. Neuropsychology. 2010. PMID: 20804250
-
Comparing individual differences in inconsistency and plasticity as predictors of cognitive function in older adults.J Clin Exp Neuropsychol. 2016;38(5):534-50. doi: 10.1080/13803395.2015.1136598. Epub 2016 Feb 22. J Clin Exp Neuropsychol. 2016. PMID: 26898536 Free PMC article.
-
Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.Schizophr Res. 2003 Sep 1;63(1-2):49-58. doi: 10.1016/s0920-9964(02)00314-6. Schizophr Res. 2003. PMID: 12892857
-
Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.Biol Psychiatry. 2004 Oct 15;56(8):560-9. doi: 10.1016/j.biopsych.2004.08.002. Biol Psychiatry. 2004. PMID: 15476685
-
Neurocognitive impairment across the lifespan in schizophrenia: an update.Schizophr Res. 2005 Apr 1;74(1):15-26. doi: 10.1016/j.schres.2004.07.005. Schizophr Res. 2005. PMID: 15694750 Review.
Cited by
-
Is there evidence for late cognitive decline in chronic schizophrenia?Psychiatr Q. 2012 Jun;83(2):127-44. doi: 10.1007/s11126-011-9189-8. Psychiatr Q. 2012. PMID: 21863346 Review.
-
Neurocognitive performance stability in a multiplex multigenerational study of schizophrenia.Schizophr Bull. 2013 Sep;39(5):1008-17. doi: 10.1093/schbul/sbs078. Epub 2012 Aug 27. Schizophr Bull. 2013. PMID: 22927671 Free PMC article.
-
Characterizing trajectories of cognitive functioning in older adults with schizophrenia: does method matter?Schizophr Res. 2013 Jan;143(1):90-6. doi: 10.1016/j.schres.2012.10.033. Epub 2012 Dec 5. Schizophr Res. 2013. PMID: 23218560 Free PMC article.
-
Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study.Eur Arch Psychiatry Clin Neurosci. 2021 Dec;271(8):1465-1473. doi: 10.1007/s00406-020-01138-7. Epub 2020 May 16. Eur Arch Psychiatry Clin Neurosci. 2021. PMID: 32417958 Free PMC article.
-
Cognitive impairment in schizophrenia: a life span perspective.Am J Alzheimers Dis Other Demen. 2007 Oct-Nov;22(5):398-405. doi: 10.1177/1533317507304745. Am J Alzheimers Dis Other Demen. 2007. PMID: 17959875 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical